About PetVivo Holdings
Advancing animal health through innovation
PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) is an emerging biomedical device company currently focused on the manufacturing, commercialization, and licensing of innovative medical devices and therapeutics for companion animals.
Our Strategy
The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.
Innovation Pipeline
PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protect the Company's biomaterials, products, production processes, and methods of use.
Proven Track Record
Demonstrating consistent growth and market leadership
Who We Are
Our leadership team is made up of animal health and medical device industry veterans with deep knowledge, vast experience and a passion for innovation.
John Lai
CEO, President & Director
Garry Lowenthal
Chief Financial Officer
John Dolan
Chief Business Development Officer & General Counsel
April Boyce
Vice President of Sales & Marketing
Josh Wilhelm
Vice President of R&D & Clinical Trials
Bryan Monninger
Vice President of Distributor Relations & Corporate Accounts
Ready to Learn More?
Discover how PetVivo is revolutionizing veterinary care with AI-powered technology.